| 000 | 02455cam a2200277zu 4500 | ||
|---|---|---|---|
| 001 | 88962665 | ||
| 003 | FRCYB88962665 | ||
| 005 | 20250429180317.0 | ||
| 006 | m o d | ||
| 007 | cr un | ||
| 008 | 250429s2020 fr | o|||||0|0|||eng d | ||
| 020 | _a9780128196212 | ||
| 035 | _aFRCYB88962665 | ||
| 040 |
_aFR-PaCSA _ben _c _erda |
||
| 100 | 1 | _aOstojic, Sergej M. | |
| 245 | 0 | 1 |
_aClinical Bioenergetics _bFrom Pathophysiology to Clinical Translation _c['Ostojic, Sergej M.'] |
| 264 | 1 |
_bAcademic Press _c2020 |
|
| 300 | _a p. | ||
| 336 |
_btxt _2rdacontent |
||
| 337 |
_bc _2rdamdedia |
||
| 338 |
_bc _2rdacarrier |
||
| 650 | 0 | _a | |
| 700 | 0 | _aOstojic, Sergej M. | |
| 856 | 4 | 0 |
_2Cyberlibris _uhttps://international.scholarvox.com/netsen/book/88962665 _qtext/html _a |
| 520 | _aClinical Bioenergetics: From Pathophysiology to Clinical Translation provides recent developments surrounding the etiology and pathophysiology of inherited and acquired energy-delated disorders. Across 40 chapters, world leaders in bioenergetics and mitochondrial medicine discuss novel methodologies designed to identify deficiencies in cellular bioenergetics, as well as the safety and efficacy of emerging management strategies to address poor cellular bioenergetics. Topics discussed include the omics landscape of impaired mitochondrial bioenergetics, hormones, tissue bioenergetics and metabolism in humans. Disease-specific case studies, modes of analysis in clinical bioenergetics, and therapeutic opportunities for impaired bioenergetics, addressing both known treatment pathways and future directions for research, are discussed in-depth. Diseases and Disorders examined include brain injury, chronic fatigue syndrome, psychiatric disorders, pulmonary fibrosis, neurodegenerative disorders, heart failure, chronic kidney disease, obesity, and insulin resistance, among others. - Provides a thorough discussion of foundational aspects of bioenergetics and disease, modes of analysis, and treatments for impaired bioenergetics - Discusses the role of bioenergetics and treatment pathways in brain injury, chronic fatigue syndrome, psychiatric disorders, pulmonary fibrosis, neurodegenerative disorders, heart failure, chronic kidney disease, obesity, and insulin resistance, among other diseases and disorders - Features chapter contributions from international leaders in translational bioenergetics research and clinical practice | ||
| 999 |
_c1322021 _d1322021 |
||